HYBIO PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.88 CNY | +5.31% |
|
+6.98% | -5.15% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Hybio Pharmaceutical Co., Ltd. is a China-based company principally involved in the development, manufacture and distribution of chemical synthetic polypeptide pharmaceuticals. The Companyâs products include polypeptide preparations, polypeptide active pharmaceutical ingredients (APIs) and customer polypeptide, among which the preparation products include thymopentin for injection, somatostatin for injection, desmopressin for injection and terlipressin for injection, among others. Through its subsidiaries, the Company's newly added products are pharmaceutical packaging products, medical devices and solid products. The Company is also engaged in provision of related technological services.
Sector
Pharmaceuticals
Calendar
2024-05-17
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -5.15% | 1.49B | |
| +19.27% | 43.75B | |
| +24.69% | 22.06B | |
| +15.11% | 14.46B | |
| +12.33% | 13.62B | |
| +38.36% | 11.61B | |
| -8.57% | 6.9B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +10.21% | 5.32B |
- Stock Market
- Equities
- 300199 Stock
- News Hybio Pharmaceutical Co., Ltd.
- Hybio Pharmaceutical Gets Regulatory Nod to Test Weight Management Injection; Shares Up 5%
